Report cover image

Global Virtual Clinical Trials Market Growth, Size, Trends Analysis - By Study Design, By Indication, By Phase - Regional Outlook, Competitive Strategies and Segment Forecast to 2034

Publisher SPER Market Research Pvt. Ltd.
Published Jun 30, 2025
Length 244 Pages
SKU # SPER20295364

Description

Virtual Clinical Trials Market Introduction and Overview

According to SPER market research, ‘Global Virtual Clinical Trials Market Growth, Size, Trends Analysis – By Study Design, By Indication, By Phase – Regional Outlook, Competitive Strategies and Segment Forecast to 2034’ state that the Global Virtual Clinical Trials Market is predicted to reach 16.52 billion by 2034 with a CAGR of 5.95%.

Virtual clinical trials, also known as decentralised clinical trials or remote clinical trials, are a new approach to clinical research in which some or all of the trial procedures are carried out remotely using digital technologies and decentralised methodologies. This implies that participants can take part in the trial from the comfort of their own homes or other convenient locations, providing data, interacting with healthcare providers, and participating in study-related activities using digital devices and platforms.

Restraints:
The rigorous laws and regulations are projected to stifle expansion in the worldwide virtual clinical trials market. The challenges and complexity associated with virtual clinical trials are another factor preventing the sector from expanding. There are various hurdles to virtual clinical trials, including data protection, regulatory compliance, and standard operating procedures. The privacy of patient data is a key problem.

Scope of the report:

Report Metric Details

Market size available for years 2021-2034

Base year considered 2024

Forecast period 2025-2034

Segments covered

By Study Design, By Indication, By Phase

Regions covered

North America, Latin America, Asia-Pacific, Europe, and Middle East & Africa

Companies Covered

ICON, plc, Parexel International Corporation, IQVIA, Covance, PRA Health Sciences, LEO Innovation Lab, Medidata, Oracle, CRF Health Clinical Ink Medable, Inc.

Global Virtual Clinical Trials Market Segmentation:

By Study Design:
Based on the Study Design, Global Virtual Clinical Trials Market is segmented as; Interventional, Observational, Expanded Access.

By Indication:
Based on the Indication, Global Virtual Clinical Trials Market is segmented as; CNS, Autoimmune/Inflammation, Cardiovascular Disease, Metabolic/Endocrinology, Infectious Disease, Oncology, Genitourinary, Ophthalmology, Others.

By Phase:
Based on the Phase, Global Virtual Clinical Trials Market is segmented as; Phase I, Phase II, Phase III, Phase IV.

By Region:
This research also includes data for North America, Latin America, Asia-Pacific, Europe, Middle East & Africa

Table of Contents

244 Pages
1. Introduction
1.1.Scope of the report
1.2.Market segment analysis
2.Research Methodology
2.1.Research data source
2.1.1.Secondary Data
2.1.2.Primary Data
2.1.3.SPERs internal database
2.1.4.Premium insight from KOLs
2.2.Market size estimation
2.2.1.Top-down and Bottom-up approach
2.3.Data triangulation
3.Executive Summary
4.Market Dynamics
4.1.Driver, Restraint, Opportunity and Challenges analysis
4.1.1.Drivers
4.1.2.Restraints
4.1.3.Opportunities
4.1.4.Challenges
5.Market variable and outlook
5.1.SWOT Analysis
5.1.1.Strengths
5.1.2.Weaknesses
5.1.3.Opportunities
5.1.4.Threats
5.2.PESTEL Analysis
5.2.1.Political Landscape
5.2.2.Economic Landscape
5.2.3.Social Landscape
5.2.4.Technological Landscape
5.2.5.Environmental Landscape
5.2.6.Legal Landscape
5.3.PORTER’s Five Forces
5.3.1.Bargaining power of suppliers
5.3.2.Bargaining power of buyers
5.3.3.Threat of Substitute
5.3.4.Threat of new entrant
5.3.5.Competitive rivalry
5.4.Heat Map Analysis
6.Competitive Landscape
6.1.Global Virtual Clinical Trials Market Manufacturing Base Distribution, Sales Area, Product Type
6.2.Mergers & Acquisitions, Partnerships, Product Launch, and Collaboration in Global Virtual Clinical Trials Market
7.Global Virtual Clinical Trials Market, By Study Design (USD Million) 2021-2034
7.1.Interventional
7.2.Observational
7.3.Expanded Access
8.Global Virtual Clinical Trials Market, By Indication (USD Million) 2021-2034
8.1.CNS
8.2.Autoimmune/Inflammation
8.3.Cardiovascular Disease
8.4.Metabolic/Endocrinology
8.5.Infectious Disease
8.6.Oncology
8.7.Genitourinary
8.8.Ophthalmology
8.9.Others
9.Global Virtual Clinical Trials Market, By Phase (USD Million) 2021-2034
9.1.Phase I
9.2.Phase II
9.3.Phase III
9.4.Phase IV
10.Global Virtual Clinical Trials Market, (USD Million) 2021-2034
10.1.Global Virtual Clinical Trials Market Size and Market Share
11.Global Virtual Clinical Trials Market, By Region, (USD Million) 2021-2034
11.1.Asia-Pacific
11.1.1.Australia
11.1.2.China
11.1.3.India
11.1.4.Japan
11.1.5.South Korea
11.1.6.Rest of Asia-Pacific
11.2.Europe
11.2.1.France
11.2.2.Germany
11.2.3.Italy
11.2.4.Spain
11.2.5.United Kingdom
11.2.6.Rest of Europe
11.3.Middle East and Africa
11.3.1.Kingdom of Saudi Arabia
11.3.2.United Arab Emirates
11.3.3.Qatar
11.3.4.South Africa
11.3.5.Egypt
11.3.6.Morocco
11.3.7.Nigeria
11.3.8.Rest of Middle-East and Africa
11.4.North America
11.4.1.Canada
11.4.2.Mexico
11.4.3.United States
11.5.Latin America
11.5.1.Argentina
11.5.2.Brazil
11.5.3.Rest of Latin America
12.Company Profile
12.1.ICON, plc
12.1.1.Company details
12.1.2.Financial outlook
12.1.3.Product summary
12.1.4.Recent developments
12.2.Parexel International Corporation
12.2.1.Company details
12.2.2.Financial outlook
12.2.3.Product summary
12.2.4.Recent developments
12.3.IQVIA
12.3.1.Company details
12.3.2.Financial outlook
12.3.3.Product summary
12.3.4.Recent developments
12.4.Covance
12.4.1.Company details
12.4.2.Financial outlook
12.4.3.Product summary
12.4.4.Recent developments
12.5.PRA Health Sciences
12.5.1.Company details
12.5.2.Financial outlook
12.5.3.Product summary
12.5.4.Recent developments
12.6.LEO Innovation Lab
12.6.1.Company details
12.6.2.Financial outlook
12.6.3.Product summary
12.6.4.Recent developments
12.7.Medidata
12.7.1.Company details
12.7.2.Financial outlook
12.7.3.Product summary
12.7.4.Recent developments
12.8.Oracle
12.8.1.Company details
12.8.2.Financial outlook
12.8.3.Product summary
12.8.4.Recent developments
12.9.CRF Health
12.9.1.Company details
12.9.2.Financial outlook
12.9.3.Product summary
12.9.4.Recent developments
12.10.Clinical Ink
12.10.1.Company details
12.10.2.Financial outlook
12.10.3.Product summary
12.10.4.Recent developments
12.11.Medable, Inc
12.11.1.Company details
12.11.2.Financial outlook
12.11.3.Product summary
12.11.4.Recent developments
12.12.Signant Health
12.12.1.Company details
12.12.2.Financial outlook
12.12.3.Product summary
12.12.4.Recent developments
12.13.Others
13.Conclusion
14.List of Abbreviations
15.Reference Links

Pricing

Currency Rates
How Do Licenses Work?

How Do Licenses Work?

The primary function of a report license is to define how many people within a company are authorized to use the purchased report. This is separate to how a report might be delivered. Unless specifically identified otherwise, the purchase option is Single User. Below is a helpful description of that license, along with a sampling of others most commonly offered.

  • This license allows only one user to have access to and to use/read the report. It is not one user at a time or one user group; it is an individual who will be reading and utilizing the report.

  • This license allows for the entire purchasing company to read and use the report. This is the license level that would allow for a report to be placed on an internal company shared drive for access by all employees of that direct company. This license does not extend to parent or sister company use.

  • This license is designed to allow an entire department within a company full access to a report. The departmental license is a great option for companies that have more than one location and the department is spread out all over the country/world

  • This license is for companies that have one location where they want the report to be accessible by all employees within that physical location.

  • This is the most flexible of the licensing options. Some publishers will allow you to get a license for a preset number of people (typically 5). These licenses are ideal for small work groups.

License options are at the discretion of each publisher. As such, not all licenses indicated above are available for every product. If you are uncertain of the best license for your needs or would like a license that is not proactively available, please contact us and we will be happy to assist.

Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
Chat Now
Contact Us